Cerevel Therapeutics Holdings (CERE) Competitor Comparison
We are evaluating the key criteria listed to compare Cerevel Therapeutics Holdings (CERE) against its competitors in the Biotechnology industry.
Market Capitalization
25 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
317 / 337Free Cashflow
326 / 352Quick Ratio
97 / 357Earnings per Share
248 / 359Dividend yield
0 / 6Total Cash
41 / 358Performance 3 years
51 / 368Performance 5 years
44 / 368Performance 10 years
39 / 368Linearity 3 years
157 / 368Linearity 5 years
335 / 368Linearity 10 years
333 / 368Total Rank
302 / 368Dividend Rank
84 / 368Valuation Rank
309 / 368Piotroski Rank
266 / 368Muliplier Rank
310 / 368Muliplier Rank - CERE ranking 310 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.